Cholesterol-lowering drug slows progression of eye disease in people with diabetes: Clinical trial
The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%. The results were announced at the American Diabetes Association Scientific ...
Jun 24, 2024
0
37